Palisade Bio, Inc. (PALI)
USD 1.75
(-7.89%)
USD 1.75
(-7.89%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -11.13 Million | -13.36 Million | -14.77 Million | -4.76 Million | -7.25 Million | -7.69 Million |
| Net Income | -12.31 Million | -14.26 Million | -26.61 Million | -10.32 Million | -8.35 Million | -4.92 Million |
| Depreciation & Amortization | 4000.00 | 3000.00 | 2000.00 | 3000.00 | 143.85 Thousand | 185.8 Thousand |
| Deferred income taxes | - | - | -20.06 Million | -38 Thousand | -3.35 Million | - |
| Stock-based compensation | 624 Thousand | 1.03 Million | 1.89 Million | 2.01 Million | 3.32 Million | 1.09 Million |
| Change in working capital | 400 Thousand | 1.25 Million | -4.75 Million | 2.38 Million | 208.28 Thousand | -336.88 Thousand |
| Other non-cash items | 1.27 Million | -1.38 Million | 34.77 Million | 1.18 Million | 774.29 Thousand | -2.28 Million |
| Investing Cash Flow | -4000.00 | -10 Thousand | -54 Thousand | -6000.00 | 3.92 Million | 4.99 Million |
| Investments in PPE | -4000.00 | -10 Thousand | - | -6000.00 | - | -1714.00 |
| Acquisitions | - | - | -54 Thousand | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | 5 Million |
| Other Investing Activities | - | - | -54 Thousand | - | - | - |
| Financing Cash Flow | 11.18 Million | 15.25 Million | 24.6 Million | 1.89 Million | 6.58 Million | 1.81 Million |
| Debt repayment | -391 Thousand | -790 Thousand | -183 Thousand | -27 Thousand | -36.42 Thousand | -13.76 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 17 Thousand | - | -99 Thousand | - | - | - |
| Common Stock Issuance | 11.57 Million | 14.4 Million | 25.04 Million | 1.17 Million | 6.55 Million | 1.82 Million |
| Other Financing Activities | 11.57 Million | 1.64 Million | 24.79 Million | 742 Thousand | 10.22 Million | 207 Thousand |
| Accounts receivables | - | - | 84 Thousand | -59 Thousand | 272.99 Thousand | 80.8 Thousand |
| Accounts payables | -492 Thousand | 399 Thousand | -2.39 Million | 1 Million | -15.74 Thousand | -36.99 Thousand |
| Inventory | - | - | -84 Thousand | -947 Thousand | 15.74 Thousand | 36.99 Thousand |
| Other working capital | 892 Thousand | 851 Thousand | -2.36 Million | 2.38 Million | -48.96 Thousand | -380.69 Thousand |
| Cash at beginning of period | 12.38 Million | 10.52 Million | 739 Thousand | 3.62 Million | 5.78 Million | 6.67 Million |
| Cash at end of period | 12.43 Million | 12.4 Million | 10.52 Million | 739 Thousand | 5.11 Million | 5.78 Million |
| Capital Expenditure | -4000.00 | -10 Thousand | - | -6000.00 | - | -1714.00 |
| Effect of forex changes on cash | - | - | - | - | -6018.00 | -7930.00 |
| Net cash flow / Change in cash | 49 Thousand | 1.88 Million | 9.78 Million | -2.88 Million | -672.19 Thousand | -887.83 Thousand |
| Free Cash Flow | -11.13 Million | -13.37 Million | -14.77 Million | -4.77 Million | -7.25 Million | -7.69 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.08 Million | -3.52 Million | -2.97 Million | -12.31 Million | -3.59 Million | -3.39 Million |
| Depreciation & Amortization | 1000.00 | 1000.00 | - | 4000.00 | 1000.00 | 2000.00 |
| Deferred income taxes | - | - | 16 Thousand | - | - | -16 Thousand |
| Stock-based compensation | 362 Thousand | 118 Thousand | 185 Thousand | 624 Thousand | 202 Thousand | 144 Thousand |
| Change in working capital | 112 Thousand | 196 Thousand | 22 Thousand | 400 Thousand | 493 Thousand | 1.14 Million |
| Other non-cash items | 579 Thousand | -463 Thousand | 511 Thousand | 1.27 Million | 238 Thousand | -83 Thousand |
| Investing Cash Flow | - | - | - | -4000.00 | - | -4000.00 |
| Investments in PPE | - | - | - | -4000.00 | - | -4000.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 3.57 Million | 2.02 Million | -134 Thousand | 11.18 Million | 1.57 Million | 5.3 Million |
| Debt repayment | - | -158 Thousand | -101 Thousand | -391 Thousand | -152 Thousand | -50 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 11 Thousand | - | 17 Thousand | 17 Thousand | - | - |
| Common Stock Issuance | 3.62 Million | 2.5 Million | -33 Thousand | 11.57 Million | 1.72 Million | 5.35 Million |
| Other Financing Activities | -47 Thousand | -321 Thousand | -33 Thousand | 11.57 Million | 1.72 Million | 5.35 Million |
| Accounts receivables | - | - | - | - | - | 250 Thousand |
| Accounts payables | -109 Thousand | 615 Thousand | -308 Thousand | -492 Thousand | 183 Thousand | 603 Thousand |
| Inventory | - | - | 853 Thousand | - | - | -853 Thousand |
| Other working capital | 221 Thousand | -419 Thousand | 330 Thousand | 892 Thousand | 310 Thousand | 1.14 Million |
| Cash at beginning of period | 11.27 Million | 12.43 Million | 15.31 Million | 12.38 Million | 16.42 Million | 13.32 Million |
| Cash at end of period | 11.35 Million | 11.27 Million | 12.43 Million | 12.43 Million | 15.33 Million | 16.42 Million |
| Capital Expenditure | - | - | - | -4000.00 | - | -4000.00 |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 77 Thousand | -1.15 Million | -2.88 Million | 49 Thousand | -1.09 Million | 3.1 Million |
| Free Cash Flow | -3.49 Million | -3.18 Million | -2.74 Million | -11.13 Million | -2.66 Million | -2.2 Million |
CACO
016610
BIOCON
QRON
601008
8273